NALOXONE HYDROCHLORIDE INJECTION
Generic: NALOXONE HYDROCHLORIDE
KaleoManufacturer
INTRAMUSCULAR, SUBCUTANEOUSRoute
NALOXONE HYDROCHLORIDEActive Substance
2022-02-28Original Approval
NALOXONE HYDROCHLORIDE INJECTION is FDA application NDA215457, sponsored by KALEO INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
TOXICITY TO VARIOUS AGENTS
808 reports
2
DRUG INEFFECTIVE
580 reports
3
OVERDOSE
478 reports
4
OFF LABEL USE
361 reports
5
NAUSEA
324 reports
6
VOMITING
262 reports
7
DEATH
258 reports
8
ACUTE KIDNEY INJURY
235 reports
9
PAIN
235 reports
10
HYPOTENSION
227 reports